Podcast Dr. GPCR Podcast par Dr. Yamina Berchiche

The #DrGPCR Ecosystem is all about dynamic interactions between us working towards exploiting the druggability of # GPCRs. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.

-------------------------------------------

To build our #GPCR Ecosystem, we created various enabling outlets.

-------------------------------------------

Are you a #GPCR professional?

Problem solving through GPCR data analysis - Sam Hoare

jeudi 8 août 2024 • Durée 02:17:16

⁠⁠⁠⁠⁠⁠⁠Watch the video version of this podcast episode.⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

-------------------------------------------

⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Become a #DrGPCR Ecosystem Member ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

-------------------------------------------

Imagine a world in which the vast majority of us are healthy.

The #DrGPCR Ecosystem is all about dynamic interactions between us working towards exploiting the druggability of # GPCRs. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.

-------------------------------------------

To build our #GPCR Ecosystem, we created various enabling outlets.

-------------------------------------------

Are you a #GPCR professional?

#155 - Re-cap of Endocrine Metabolic GPCR 2024

Saison 1 · Épisode 155

jeudi 13 juin 2024 • Durée 27:30

⁠⁠⁠⁠⁠⁠Watch the video version of this podcast episode.⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

-------------------------------------------

⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Become a #DrGPCR Ecosystem Member ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

-------------------------------------------

Imagine a world in which the vast majority of us are healthy.

The #DrGPCR Ecosystem is all about dynamic interactions between us working towards exploiting the druggability of # GPCRs. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.

-------------------------------------------

To build our #GPCR Ecosystem, we created various enabling outlets.

-------------------------------------------

Are you a #GPCR professional?

Revisit - Dr. Paul Insel

Saison 1

jeudi 28 juillet 2022 • Durée 54:23

Watch the video version of this podcast episode

https://www.ecosystem.drgpcr.com/dr-gpcr-podcast

-------------------------------------------

Learn more about Dr. Paul Insel

https://www.ecosystem.drgpcr.com/search?q=paul+insel

-------------------------------------------

How Users can benefit Dr. GPCR Ecosystem?

https://www.ecosystem.drgpcr.com/explore-individuals

-------------------------------------------

How Organizations can benefit from Dr. GPCR Ecosystem?

https://www.ecosystem.drgpcr.com/explore-organizations

-------------------------------------------

Become a #DrGPCR Ecosystem Member

https://www.ecosystem.drgpcr.com/plans-pricing

-------------------------------------------

Imagine a world in which the vast majority of us are healthy.

The #DrGPCR Ecosystem is all about dynamic interactions between us who are working towards exploiting the druggability of #GPCR's. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.

To build our #GPCR Ecosystem, we created various enabling outlets.

- Individuals

https://www.ecosystem.drgpcr.com/explore-individuals

- Organizations

https://www.ecosystem.drgpcr.com/explore-organizations

-------------------------------------------

Are you a #GPCR professional?

- Subscribe to #DrGPCR monthly newsletter

http://www.drgpcr.com/newsletter/

- Listen and subscribe to #DrGPCR Podcasts

http://www.drgpcr.com/podcast/

- Listen and watch GPCR focused scientific talks at #VirtualCafe

https://www.drgpcr.com/virtual-cafe/

Revisit - Dr. Nicola J. Smith

Saison 1

jeudi 21 juillet 2022 • Durée 01:35:06

Watch the video version of this podcast episode

https://www.ecosystem.drgpcr.com/dr-gpcr-podcast

-------------------------------------------

Learn more about Dr. Nicola J. Smith

https://www.ecosystem.drgpcr.com/search?q=Nicola+Smith

-------------------------------------------

How Users can benefit Dr. GPCR Ecosystem?

https://www.ecosystem.drgpcr.com/explore-individuals

-------------------------------------------

How Organizations can benefit from Dr. GPCR Ecosystem?

https://www.ecosystem.drgpcr.com/explore-organizations

-------------------------------------------

Become a #DrGPCR Ecosystem Member

https://www.ecosystem.drgpcr.com/plans-pricing

-------------------------------------------

Imagine a world in which the vast majority of us are healthy.

The #DrGPCR Ecosystem is all about dynamic interactions between us who are working towards exploiting the druggability of #GPCR's. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.

To build our #GPCR Ecosystem, we created various enabling outlets.

- Individuals

https://www.ecosystem.drgpcr.com/explore-individuals

- Organizations

https://www.ecosystem.drgpcr.com/explore-organizations

-------------------------------------------

Are you a #GPCR professional?

- Subscribe to #DrGPCR monthly newsletter

http://www.drgpcr.com/newsletter/

- Listen and subscribe to #DrGPCR Podcasts

http://www.drgpcr.com/podcast/

- Listen and watch GPCR focused scientific talks at #VirtualCafe

https://www.drgpcr.com/virtual-cafe/

Revisit - Dr. Bryan Roth

Saison 1

jeudi 14 juillet 2022 • Durée 01:14:22

Watch the video version of this podcast episode

https://www.ecosystem.drgpcr.com/dr-gpcr-podcast

-------------------------------------------

Learn more about Dr. Bryan Roth

https://www.ecosystem.drgpcr.com/search?q=Bryan+Roth

-------------------------------------------

How Users can benefit Dr. GPCR Ecosystem?

https://www.ecosystem.drgpcr.com/explore-individuals

-------------------------------------------

How Organizations can benefit from Dr. GPCR Ecosystem?

https://www.ecosystem.drgpcr.com/explore-organizations

-------------------------------------------

Become a #DrGPCR Ecosystem Member

https://www.ecosystem.drgpcr.com/plans-pricing

-------------------------------------------

Imagine a world in which the vast majority of us are healthy.

The #DrGPCR Ecosystem is all about dynamic interactions between us who are working towards exploiting the druggability of #GPCR's. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.

To build our #GPCR Ecosystem, we created various enabling outlets.

- Individuals

https://www.ecosystem.drgpcr.com/explore-individuals

- Organizations

https://www.ecosystem.drgpcr.com/explore-organizations

-------------------------------------------

Are you a #GPCR professional?

- Subscribe to #DrGPCR monthly newsletter

http://www.drgpcr.com/newsletter/

- Listen and subscribe to #DrGPCR Podcasts

http://www.drgpcr.com/podcast/

- Listen and watch GPCR focused scientific talks at #VirtualCafe

https://www.drgpcr.com/virtual-cafe/

Revisit - Dr. Graciela Pineyro

Saison 1

jeudi 7 juillet 2022 • Durée 53:42

Watch the video version of this podcast episode

https://www.ecosystem.drgpcr.com/dr-gpcr-podcast

-------------------------------------------

Learn more about Dr. Graciela Pineyro

https://www.ecosystem.drgpcr.com/search?q=Graciela+Pineyro

-------------------------------------------

How Users can benefit Dr. GPCR Ecosystem?

https://www.ecosystem.drgpcr.com/explore-individuals

-------------------------------------------

How Organizations can benefit from Dr. GPCR Ecosystem?

https://www.ecosystem.drgpcr.com/explore-organizations

-------------------------------------------

Become a #DrGPCR Ecosystem Member

https://www.ecosystem.drgpcr.com/plans-pricing

-------------------------------------------

Imagine a world in which the vast majority of us are healthy.

The #DrGPCR Ecosystem is all about dynamic interactions between us who are working towards exploiting the druggability of #GPCR's. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.

To build our #GPCR Ecosystem, we created various enabling outlets.

- Individuals

https://www.ecosystem.drgpcr.com/explore-individuals

- Organizations

https://www.ecosystem.drgpcr.com/explore-organizations

-------------------------------------------

Are you a #GPCR professional?

- Subscribe to #DrGPCR monthly newsletter

http://www.drgpcr.com/newsletter/

- Listen and subscribe to #DrGPCR Podcasts

http://www.drgpcr.com/podcast/

- Listen and watch GPCR focused scientific talks at #VirtualCafe

https://www.drgpcr.com/virtual-cafe/

#80 with Dr. Andrew Tobin

Saison 1 · Épisode 80

jeudi 30 juin 2022 • Durée 53:03

For more details, visit the #DrGPCR Podcast Episode #80 page https://www.drgpcr.com/episode-80-with-andrew-tobin/ ------------------------------------------- About Dr. Andrew Tobin

Andrew Tobin studied Biochemistry at Queen Mary College, the University of London obtaining first-class honors before studying for a D.Phil at the University of Oxford. Following a post-doctoral period at Bristol Myers Squibb in Princeton USA, Andrew returned to the UK to establish his own laboratory at the University of Leicester. Funded through three consecutive Wellcome Trust Senior Research Fellowships Andrew established a reputation in the field of receptor signaling.

Now at the University of Glasgow, his primary research interests are focused on the rational design of novel drugs to treat the three global health challenges of dementia, asthma, and malaria. In this Andrew runs a research laboratory of around 15 staff supported by basic research grants investigating aspects of disease biology and the action of drugs in the context of disease. The vehicle by which Andrew is translating fundamental findings to commercial products is Keltic Pharma Therapeutics Ltd, a biotechnology company co-founded by Andrew with series A funding from the European Union.

Andrew is also the Director of the Advanced Research Centre (ARC) a collaborative initiative at the University of Glasgow underpinned by a £118M new build that will house over 550 researchers designed to drive interdisciplinary research.

Dr. Andrew Tobin on the web

-------------------------------------------

Become a #DrGPCR Ecosystem Member

-------------------------------------------

Imagine a world in which the vast majority of us are healthy.

The #DrGPCR Ecosystem is all about dynamic interactions between us who are working towards exploiting the druggability of #GPCR's. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.

To build our #GPCR Ecosystem, we created various enabling outlets.

-------------------------------------------

Are you a #GPCR professional?

#79 with Dr. Graeme Milligan

Saison 1 · Épisode 79

jeudi 23 juin 2022 • Durée 55:16

For more details, visit the #DrGPCR Podcast Episode #79 page http://www.drgpcr.com/episode-79-with-graeme-milligan/ ------------------------------------------- About Dr. Graeme Milligan

Professor Graeme Milligan is Gardiner Professor of Biochemistry, Dean of Research, and Deputy Head of the College of Medical, Veterinary, and Life Sciences at the University of Glasgow. His main research group centers on the function, structure, and regulation of G protein-coupled receptors (GPCRs) and their interacting proteins. His experience also includes translating knowledge generated into the selection of targets, screening, and identification of small molecule regulators of these proteins, and progressing such ligands in drug development programs.

Prof. Milligan has published more than 550 peer-reviewed articles and his research has been cited more than 35,000 times. He was elected to the Fellowship of the Royal Society of Edinburgh in 1998 and to the Fellowship of the Academy of Medical Sciences in 2016.

Prof. Milligan is the co-founder of both Caldan Therapeutics (2015) which discovers novel therapeutics for metabolic diseases including Type 2 Diabetes and other indications including non-alcoholic steatohepatitis (NASH) and inflammatory diseases and Keltic Pharma Therapeutics (2020) which is developing new treatments for malaria.

Dr. Graeme Milligan on the web

-------------------------------------------

Become a #DrGPCR Ecosystem Member

-------------------------------------------

Imagine a world in which the vast majority of us are healthy.

The #DrGPCR Ecosystem is all about dynamic interactions between us who are working towards exploiting the druggability of #GPCR's. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.

To build our #GPCR Ecosystem, we created various enabling outlets.

-------------------------------------------

Are you a #GPCR professional?

#78 with Dr. Stuart Maudsley

Saison 1 · Épisode 78

jeudi 16 juin 2022 • Durée 01:37:51

For more details, visit the #DrGPCR Podcast Episode #78 page https://www.drgpcr.com/episode-78-with-stuart-maudsley/ ------------------------------------------- About Dr. Stuart Maudsley

Stuart graduated from the University of Leeds in the U.K. with a First Class Honors degree in Pharmacology. At the end of his studies, he was awarded the Pfizer Prize for undergraduate research. He then completed his Ph.D. at Leeds as well as the University’s Ackroyd, Brotherton, and Brown Scholar.

Following his Ph.D., Dr. Maudsley was awarded a Howard Hughes Medical Institute Fellowship to train with Professor Robert Lefkowitz at Duke University. Following this tremendous experience, he was recruited to be the Principal Investigator of the Receptor Biology Section at the Medical Research Council (MRC) -Human Reproductive Sciences Unit within the University of Edinburgh.

At the MRC he developed novel prostate cancer therapeutics based upon his research into GPCR pluridimensional signaling. To broaden his biomedical skill-set Stuart next accepted the position of Head of the Receptor Pharmacology Unit at the National Institutes of Health – National Institute on Aging at the Johns Hopkins University Medical Center. At the NIH he was the recipient of the coveted NIH ‘Bench-to-Bedside’ Translational Research Grant Award, one of the few awards available within the intramural NIH program. Upon starting a new family, and returning to Europe, Dr. Maudsley continued his scientific journey with the award of the highly-valued Odysseus Program Type I Program Grant to work as both the Adjunct Director of the VIB Center for Molecular Neurology and also Vice-Chair of the Department of Biomedical Sciences at the University of Antwerp.

Stuart’s current research, in the Receptor Biology Lab, focuses on the development of novel GPCR-based therapeutics that interdict diseases based on their gerontological underpinnings. This research stream is now forming the basis of a new technology-based start-up company, HeptOME, to help screen and develop novel longevity/disease-regulating compounds with multidimensional disease efficacy profiles.

-------------------------------------------

Become a #DrGPCR Ecosystem Member

-------------------------------------------

Imagine a world in which the vast majority of us are healthy.

The #DrGPCR Ecosystem is all about dynamic interactions between us who are working towards exploiting the druggability of #GPCR's. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.

To build our #GPCR Ecosystem, we created various enabling outlets.

-------------------------------------------

Are you a #GPCR professional?